Dianalitics
Global Indemnity Group
GBLI · v1 · 2026-09-08
arrow_back
homeHomemonitoringPerformancesearch
hourglass
Loading…
Preparing the latest DD data, styles and content.
57NeutralDD: Sep 08, 2026Analyst: 68
paidPrice at analysis date
USD 30.4 (08/09/2026)
domainMkt cap
$444M
pie_chartShares
-
candlestick_chart52W
$24.28-$30.50
trending_downShort interest
0.1%
INFONYSEFinancialsFounded 2003
Verdict: Watch - asset-backed discount, but rerating evidence required

GBLI trades at about 0.63x book value with no debt, an A financial-strength rating and improving current-accident-year underwriting. The independent base case is $41 per share, about 35% above spot. The screen's 60% upside survives only in the bull case because low return on equity, expense inefficiency, limited liquidity and controlling-shareholder governance justify a persistent discount.

DIANALITICS RESEARCH INDEX
Score /100 - updated 2026-09-08
68
Global Indemnity Group (GBLI)
Financials / specialty property and casualty insurance
A debt-free balance sheet, investment income and improving underwriting support the asset floor. The score is capped by low normalized ROE, a high expense structure, controlled-company governance, reserve uncertainty and very low share liquidity.
Fin. strength
16
/20 pts
EBITDA/FCF
9
/15 pts
Debt/leverage
15
/15 pts
Stage/business
10
/15 pts
Catalysts
5
/10 pts
Reg. risk
4
/8 pts
Risk/reward
4
/7 pts
Management
2
/5 pts
Sector/macro
1
/3 pts
Compliance
2
/2 pts
zero debt 0.63x book value controlled company thin liquidity
Fair value bridge
Fair value base case
USD 41.0
Range: USD 24.0-USD 51.0
Price at analysis date: USD 30.4 (08/09/2026)
Base upside/downside: +35%

Weighted midpoint value is about $39.8 per share using $51 bull, $41 base and $24 bear. Cross-check 1: sponsored research's $49 target is close to the bull case, not the independent base. Cross-check 2: 12x the $2.37 FY2026 EPS estimate yields only $28.44, showing that the thesis depends on monetizing balance-sheet value rather than current earnings alone. Sensitivity: each 0.10x change in P/B moves fair value by about $4.83 per share. The initial 3.3x screen ratio is not confirmed in the independent base case. Not investment advice.

ComponentAssumptionUSD/share
Selected peer starting value$48.28 BVPS x 1.55x adjusted peer median+74.83
ROE and earnings-quality discount-0.35x BVPS; recent returns remain below quality peers-16.90
Expense-efficiency discount-0.15x BVPS; expense ratio remains above long-term objective-7.24
Control and liquidity discount-0.30x BVPS for super-voting control and thin trading-14.48
Balance-sheet premium+0.10x BVPS for zero debt and discretionary capital+4.83
FV base caseImplied 0.85x reported BVPS41.04
Bull
$49-53
Probability: 30%
Low-90s combined ratios hold, ROE approaches double digits and the board deploys excess capital. A 1.05x book multiple gives about $50.69 and confirms the screen's 60% upside path.
Base
USD 39.0-USD 43.0
Probability: 45%
Underwriting stays profitable but capital return remains gradual. A persistent governance and liquidity discount limits the rerating to roughly 0.85x book.
Bear
$23-26
Probability: 25%
Adverse reserve development or catastrophe losses weaken book value and investors continue to assign a 0.50x multiple. The hard-floor reference is $24.14.
Methodology: Weighted midpoint value is about $39.8 per share using $51 bull, $41 base and $24 bear. Cross-check 1: sponsored research's $49 target is close to the bull case, not the independent base. Cross-check 2: 12x the $2.37 FY2026 EPS estimate yields only $28.44, showing that the thesis depends on monetizing balance-sheet value rather than current earnings alone. Sensitivity: each 0.10x change in P/B moves fair value by about $4.83 per share. The initial 3.3x screen ratio is not confirmed in the independent base case. Not investment advice. Not investment advice.
warning
Main caution - cheap book value is not the same as realizable book value
The 37% discount to reported book is large, but GBLI has traded below book for structural reasons. Core earnings remain modest relative to $710.9M of equity, the company is controlled through super-voting Class B shares, trading liquidity is thin, and reserve development can alter book value after the fact. A full rerating requires sustained low-90s underwriting and explicit capital return.
check_circle
Positive anchor - debt-free capital and better underwriting
At June 30, 2026, GBLI had $1.37B of cash and invested assets net of securities payable, $710.9M of shareholders' equity and no debt. H1 current-accident-year combined ratio improved to 94.8% from 103.0%, while Q2 gross written premiums rose 9.6% and investment income rose 11.2%.
Capital Structure - Short Interest - Buyback & Dilution
Debt
$0
No debt at June 30, 2026. Cash and invested assets net of securities payable were $1.37B against $710.9M of equity.
Short interest
0.1%
11,437 shares short at the June 15, 2026 settlement, about 0.1% of float and 2.14 days to cover. This dated print indicates little short pressure.
Buyback authorization
~$101M
Estimated authorization remaining. No material open-market repurchases were identified through H1 2026; shares increased from 14.4M to 14.6M.
Capital allocation - current evidence
Book discount
37.1%
H1 dividend / share
$0.70
Share-count change
+1.4%

The annualized dividend is $1.40 per share, a 4.6% yield at $30.36. That return is tangible, but failure to repurchase shares materially below book weakens the rerating argument. No active shelf registration was identified in the current 2026 filing set; future registrations remain a monitoring item.

$Financial analysis - underwriting and investment engine
Q2 2026 gross written premiums
$117.1M
+9.6% YoY
Q2 2026 net income
$11.1M
Diluted EPS $0.76 vs $0.71
Q2 current AY combined
94.7%
Profitable underwriting; broadly flat YoY
Book value per share
$48.28
Down from $48.96 at FY2025 after dividends, AOCI and dilution
ItemFY2022FY2023FY2024FY2025H1 2026
Gross written premiums$727.6M$416.4M$389.8M$398.9M$213.5M
Net earned premiums$602.5M$473.4M$377.0M$388.8M$197.0M
Net investment incomeN/DN/DN/D$62.7M$28.6M
Net income-$1.3M$25.0M$43.2M$25.3M$15.3M
Diluted EPS-$0.09$1.83$3.12$1.75$1.05
Combined ratio98.8%99.7%95.6%98.6%94.8% current AY
Book value / share$44.87$47.53$49.98$48.96$48.28
The sharp premium decline from 2022 reflects the deliberate exit of lines and runoff activity, not a one-year collapse in the continuing franchise. H1 2026 combined ratio is current-accident-year because that is the cleanest comparable disclosed for the period.
Quarterly dynamics - selected recent quarters
MetricQ2 2025Q3 2025Q4 2025*Q1 2026Q2 2026
Gross written premiums ($M)106.8108.485.196.4117.1
Net income ($M)10.312.46.14.211.1
Diluted EPS$0.71$0.86$0.46$0.29$0.76
Current AY combined ratio94.6%90.4%N/D94.9%94.7%
*Q4 2025 premiums, net income and EPS are calculated as FY2025 less reported nine-month results; they are not separately reported quarter figures.
Balance-sheet protection and operating progress
Price / book
0.63x
Current AY combined ratio
94.8%
Debt / equity
0.0x
account_tree

Business model - specialty P&C and insurance services

The thesis is a capital-allocation and underwriting rerating, not a growth multiple
Global Indemnity owns specialty property and casualty carriers plus agency and insurance-service operations. Belmont Core writes continuing insurance and reinsurance business, Agency & Insurance Services provides distribution, underwriting and claims capabilities, and Belmont Non-Core manages exited lines. Value creation depends on profitable underwriting, investment spread and disciplined use of surplus capital.

Belmont Core Q2 gross written premiums $117.3M, +7% improving The continuing insurance and reinsurance engine. Current-accident-year underwriting income was $5.8M in Q2, up 3.2%, with a 94.7% combined ratio. Agency & Insurance Services Distribution and fee-value option to prove Includes specialty distribution and insurtech capabilities. A larger fee contribution could improve capital efficiency, but disclosure does not yet support a separate premium valuation. Belmont Non-Core Runoff and exited business runoff Legacy exposures reduce earnings clarity and create reserve-tail risk. The model gives no growth premium to this book and treats adverse development as a bear-case trigger. Investment portfolio Q2 net investment income $16.4M, +11.2% supportive Fixed maturities represent about 98% of investments. Income supports earnings, but duration, credit quality and AOCI still affect reported book value.

gavel

Legal, regulatory and risk analysis

Controlled-company governance
High
Fox Paine-related holders controlled about 83% of voting power as of April 13, 2026. Class B shares carry ten votes each, limiting minority influence and enabling Nasdaq controlled-company exemptions.
Reserve and legacy casualty tail
High
Asbestos, environmental, mass-tort and other long-tail claims are inherently uncertain. Adverse reserve development can reduce both earnings and book value, weakening the apparent asset floor.
Catastrophe volatility
High
Specialty property exposures can produce sharp quarterly losses. Reinsurance reduces but does not eliminate severity, counterparty or coverage-gap risk.
Expense-ratio execution
Moderate
Management's long-term objective is a 36%-37% expense ratio and low-90s combined ratio. Failure to improve operating efficiency would justify a sub-book valuation.
Share liquidity
High
Daily volume is often only several thousand shares. The stock can gap on modest flows, limiting position size and making quoted price a less reliable exit value.
Balance-sheet leverage
Positive
No debt and $1.37B of cash and invested assets net of securities payable provide meaningful loss-absorption capacity.
Financial-strength rating
Positive
AM Best's A (Excellent) rating for the principal insurance group supports customer and distribution confidence, subject to future rating review.
Dilution and inactive buyback
Moderate
Common shares increased about 1.4% from year-end despite a large repurchase authorization. Equity awards, including July director grants, are not open-market insider conviction.

Legal and ownership checks: the latest filings describe ordinary-course litigation and no proceeding expected to have a material adverse effect. No significant open-market insider sale above $500,000 was identified in the recent review window; July 2026 director transactions were equity awards at $26.01. GBLI's partnership-style tax structure can allocate taxable income to holders even when cash distributions differ.

article

SWOT analysis

Strengths
  • +No debt and substantial invested assets.
  • +A (Excellent) AM Best financial-strength rating.
  • +H1 2026 current-accident-year underwriting improved materially.
  • +4.6% annualized dividend yield at the reference price.
Weaknesses
  • −Normalized return on equity is low versus quality peers.
  • −Thin trading liquidity and sparse analyst coverage.
  • −Super-voting control limits minority shareholder influence.
  • −Repurchase authorization has not produced material execution.
Opportunities
  • →Sustained low-90s combined ratios can lift ROE and P/B.
  • →Buybacks below book could create immediate per-share accretion.
  • →Agency and service income can improve capital efficiency.
  • →Higher reinvestment yields can support investment income.
Threats
  • !Reserve development can invalidate the book-value anchor.
  • !Catastrophe losses can reverse quarterly underwriting gains.
  • !Rate softening can pressure premiums and underwriting margin.
  • !Persistent control and liquidity discounts can block rerating.
article

Summary by assessment area

Financial risk - low/moderate
  • Zero debt and a large fixed-income portfolio protect solvency.
  • Reserve and catastrophe risks remain intrinsic to the model.
Valuation - discounted, not distressed
  • Base FV of $41 implies 35% upside from $30.36.
  • The 67% upside screen requires the bull rerating to 1.05x book.
Catalysts - evidence required
  • Q3 underwriting, capital return and expense progress are the next checks.
  • Without buyback execution, the discount can persist despite reported book.
Sources & Disclaimer

Sources: Global Indemnity Group Q2 2026 Form 10-Q filed Aug. 6, 2026; Q2 2026 earnings release; FY2025 Form 10-K; 2026 proxy statement ownership data as of Apr. 13, 2026; May 2026 board appointment disclosure; company investor-relations capital and ratings materials; Zacks Small-Cap Research report dated Aug. 6, 2026, which discloses issuer compensation; recent StockAnalysis, Yahoo Finance, StockVS, ChartExchange and Investing.com market snapshots; Mercer Capital Q1 2026 P&C public-company review. Price row used: GBLI $30.36 - close September 4, 2026; 52-week range $24.28-$30.50; market cap approximately $444M; 14.6M total common shares; price x shares approximately $443.3M. September 4 is the latest completed U.S. session before the September 7 Labor Day holiday. Short-interest row: 11,437 shares, approximately 0.1% of float and 2.14 days to cover, June 15, 2026 settlement; it is explicitly dated because a newer reliable print was not found. This document is for informational purposes only and does not constitute financial or investment advice.